Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon C Jayson

Showing results (51-60 of 126) with videos related to

Pageof 13
Sort By:
The Journal of Organic Chemistry|February 4, 2015
Synthesis of L-iduronic acid derivatives via [3.2.1] and [2.2.2] L-iduronic lactones from bulk glucose-derived cyanohydrin hydrolysis: a reversible conformationally switched superdisarmed/rearmed lactone route to heparin disaccharidesSteen U Hansen, Charlotte E Dalton, Marek Baráth, et al.
The Journal of Biological Chemistry|February 17, 2006
The morphogenic properties of oligomeric endostatin are dependent on cell surface heparan sulfateAndrew Clamp, Fiona H Blackhall, Audrey Henrioud, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 25, 2019
Dose-dense cisplatin with gemcitabine for relapsed platinum-resistant ovarian cancerRobert D Morgan, Andrew R Clamp, Cong Zhou, et al.
Cancers|January 14, 2021
Image Contrast, Image Pre-Processing, and T<sub>1</sub> Mapping Affect MRI Radiomic Feature Repeatability in Patients with Colorectal Cancer Liver MetastasesDamien J McHugh, Nuria Porta, Ross A Little, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2010
Inhibition of carboplatin-induced DNA interstrand cross-link repair by gemcitabine in patients receiving these drugs for platinum-resistant ovarian cancerJonathan A Ledermann, Hani Gabra, Gordon C Jayson, et al.
The Journal of Organic Chemistry|August 21, 2012
Synthesis and scalable conversion of L-iduronamides to heparin-related di- and tetrasaccharidesSteen U Hansen, Gavin J Miller, Marek Baráth, et al.
Magnetic Resonance in Medicine|May 14, 2013
Indexed distribution analysis for improved significance testing of spatially heterogeneous parameter maps: application to dynamic contrast-enhanced MRI biomarkersChris J Rose, James P B O'Connor, Tim F Cootes, et al.
Journal of the National Cancer Institute|November 18, 2004
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinomaPaul A Vasey, Gordon C Jayson, Alan Gordon, et al.
Sexual Medicine|December 18, 2021
Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational StatusChloe A Logue, Julia Pugh, Philip Foden, et al.
Academic Radiology|August 29, 2006
Comparison of the performance of tracer kinetic model-driven registration for dynamic contrast enhanced MRI using different models of contrast enhancementGiovanni A Buonaccorsi, Caleb Roberts, Sue Cheung, et al.
Pageof 13

Showing results (51-60 of 126) with videos related to

Sort By:
Pageof 13
The Journal of Organic Chemistry|February 4, 2015
Synthesis of L-iduronic acid derivatives via [3.2.1] and [2.2.2] L-iduronic lactones from bulk glucose-derived cyanohydrin hydrolysis: a reversible conformationally switched superdisarmed/rearmed lactone route to heparin disaccharidesSteen U Hansen, Charlotte E Dalton, Marek Baráth, et al.
The Journal of Biological Chemistry|February 17, 2006
The morphogenic properties of oligomeric endostatin are dependent on cell surface heparan sulfateAndrew Clamp, Fiona H Blackhall, Audrey Henrioud, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 25, 2019
Dose-dense cisplatin with gemcitabine for relapsed platinum-resistant ovarian cancerRobert D Morgan, Andrew R Clamp, Cong Zhou, et al.
Cancers|January 14, 2021
Image Contrast, Image Pre-Processing, and T<sub>1</sub> Mapping Affect MRI Radiomic Feature Repeatability in Patients with Colorectal Cancer Liver MetastasesDamien J McHugh, Nuria Porta, Ross A Little, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2010
Inhibition of carboplatin-induced DNA interstrand cross-link repair by gemcitabine in patients receiving these drugs for platinum-resistant ovarian cancerJonathan A Ledermann, Hani Gabra, Gordon C Jayson, et al.
The Journal of Organic Chemistry|August 21, 2012
Synthesis and scalable conversion of L-iduronamides to heparin-related di- and tetrasaccharidesSteen U Hansen, Gavin J Miller, Marek Baráth, et al.
Magnetic Resonance in Medicine|May 14, 2013
Indexed distribution analysis for improved significance testing of spatially heterogeneous parameter maps: application to dynamic contrast-enhanced MRI biomarkersChris J Rose, James P B O'Connor, Tim F Cootes, et al.
Journal of the National Cancer Institute|November 18, 2004
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinomaPaul A Vasey, Gordon C Jayson, Alan Gordon, et al.
Sexual Medicine|December 18, 2021
Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational StatusChloe A Logue, Julia Pugh, Philip Foden, et al.
Academic Radiology|August 29, 2006
Comparison of the performance of tracer kinetic model-driven registration for dynamic contrast enhanced MRI using different models of contrast enhancementGiovanni A Buonaccorsi, Caleb Roberts, Sue Cheung, et al.
Pageof 13